TESSALON Drug Patent Profile
✉ Email this page to a colleague
When do Tessalon patents expire, and what generic alternatives are available?
Tessalon is a drug marketed by Pfizer and is included in one NDA.
The generic ingredient in TESSALON is benzonatate. There are six drug master file entries for this compound. Forty-three suppliers are listed for this compound. Additional details are available on the benzonatate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Tessalon
A generic version of TESSALON was approved as benzonatate by BIONPHARMA on January 29th, 1993.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TESSALON?
- What are the global sales for TESSALON?
- What is Average Wholesale Price for TESSALON?
Summary for TESSALON
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 51 |
| Patent Applications: | 2,390 |
| Drug Prices: | Drug price information for TESSALON |
| What excipients (inactive ingredients) are in TESSALON? | TESSALON excipients list |
| DailyMed Link: | TESSALON at DailyMed |
US Patents and Regulatory Information for TESSALON
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pfizer | TESSALON | benzonatate | CAPSULE;ORAL | 011210-001 | Approved Prior to Jan 1, 1982 | AA | RX | Yes | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Pfizer | TESSALON | benzonatate | CAPSULE;ORAL | 011210-003 | Jun 25, 1999 | DISCN | Yes | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
